XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Sep. 30, 2022
Sep. 30, 2021
OPERATING EXPENSES:    
Amortization $ 57,344 $ 57,344
Research and development expenses 6,769,932 3,094,778
Selling, general and administrative expenses 2,007,062 2,395,162
TOTAL OPERATING EXPENSES 8,834,338 5,547,284
LOSS FROM OPERATIONS (8,834,338) (5,547,284)
OTHER EXPENSE (INCOME):    
Change in fair value of derivative liabilities 566,542
Interest expense 1,056,416 1,114
Interest income (41,585) (7,645)
TOTAL OTHER EXPENSE (INCOME), NET 1,581,373 (6,531)
NET LOSS (10,415,711) (5,540,753)
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS $ (10,415,711) $ (5,540,753)
NET LOSS PER COMMON SHARE    
- Basic $ (0.38) $ (0.23)
- Diluted $ (0.38) $ (0.23)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING    
- Basic 27,212,445 23,719,927
- Diluted 27,212,445 23,719,927